Arik Elfassy
Papers
1
Total Citations
12
H-Index
1
About
Arik Elfassy is a translational researcher whose work bridges clinical microbiology and diagnostic innovation, with a primary focus on *Clostridioides difficile* infections. His most notable contribution is the development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting *C. difficile* toxins in stool samples, a study published in 2021 that has garnered 12 citations. This work addresses a critical need for rapid, reliable diagnostic tools to combat healthcare-associated diarrhea, improving patient outcomes through earlier and more accurate detection. Elfassy’s research integrates automation with traditional neutralization methods, enhancing throughput and reproducibility in clinical labs. His impact lies in refining diagnostic accuracy for a pathogen responsible for significant morbidity, offering a template for scalable toxin detection. Beyond this landmark paper, Elfassy’s expertise in assay development and clinical validation positions him as a contributor to infectious disease diagnostics, with potential implications for antimicrobial stewardship. His work is particularly relevant for researchers and clinicians seeking to streamline *C. difficile* testing in high-volume settings, demonstrating a commitment to translating laboratory science into practical, patient-centered solutions.
Research Focus
Key Achievements
Top Papers
- 1